All-trans_JJ
retinoic_JJ
acid_NN
and_CC
1_CD
alpha,25-dihydroxyvitamin_NN
D3_NN
co-operate_VBP
to_TO
promote_VB
differentiation_NN
of_IN
the_DT
human_JJ
promyeloid_JJ
leukemia_NN
cell_NN
line_NN
HL60_NN
to_TO
monocytes_NNS
._.

A_DT
basis_NN
for_IN
differentiation_NN
therapy_NN
of_IN
leukemias_NNS
is_VBZ
provided_VBN
by_IN
knowledge_NN
of_IN
agents_NNS
which_WDT
induce_VB
specific_JJ
lineage_NN
maturation_NN
._.

All-trans_JJ
retinoic_JJ
acid_NN
-LRB-_-LRB-
RA_NN
-RRB-_-RRB-
induces_VBZ
differentiation_NN
of_IN
HL60_NN
cells_NNS
to_TO
neutrophils_NNS
and_CC
is_VBZ
used_VBN
to_TO
treat_VB
acute_JJ
promyelocytic_JJ
leukemia_NN
._.

We_PRP
observed_VBD
that_IN
RA_NN
did_VBD
not_RB
induced_VBN
neutrophil_NN
differentiation_NN
in_IN
serum-free_JJ
grown_JJ
HL60_NN
cells_NNS
whereas_IN
50_CD
nM_NN
1_CD
alpha,25-dihydroxyvitamin_NN
D3_NN
-LRB-_-LRB-
D3_NN
-RRB-_-RRB-
induced_VBD
maximal_JJ
monocyte_NN
differentiation_NN
._.

Increasing_VBG
RA_NN
concentrations_NNS
reduced_VBD
the_DT
D3_NN
concentration_NN
required_VBN
for_IN
monocyte_NN
differentiation_NN
._.

Cells_NNS
treated_VBN
with_IN
5_CD
nM_NN
D3_NN
showed_VBD
little_JJ
response_NN
,_,
but_CC
differentiated_VBD
maximally_RB
with_IN
5_CD
nM_NN
D3_NN
and_CC
10_CD
nM_NN
RA_NN
._.

The_DT
D3_NN
analogs_NNS
MC903_NN
,_,
EB1089_NN
and_CC
KH1060_NN
were_VBD
more_RBR
potent_JJ
inducers_NNS
of_IN
monocyte_NN
differentiation_NN
._.

The_DT
extent_NN
to_TO
which_WDT
analog_NN
activity_NN
was_VBD
increased_VBN
after_IN
cotreatment_NN
with_IN
RA_NN
was_VBD
inversely_RB
related_JJ
to_TO
potency_NN
._.

Twenty-four_CD
hour_NN
treatment_NN
with_IN
10_CD
nM_NN
RA_NN
primed_VBD
cells_NNS
for_IN
response_NN
to_TO
5_CD
nM_NN
D3_NN
;_:
the_DT
reverse_JJ
sequence_NN
being_VBG
ineffective_JJ
._.

Priming_NN
with_IN
10_CD
nM_NN
RA_NN
,_,
or_CC
subsequent_JJ
treatment_NN
with_IN
D3_NN
-LRB-_-LRB-
5_CD
nM_NN
-RRB-_-RRB-
,_,
did_VBD
not_RB
alter_VB
expression_NN
of_IN
mRNAs_NNS
encoding_VBG
receptors_NNS
for_IN
D3_NN
-LRB-_-LRB-
VDR_NN
-RRB-_-RRB-
,_,
RA_NN
-LRB-_-LRB-
RAR_NN
alpha_NN
-RRB-_-RRB-
or_CC
9-CIS_JJ
RA_NN
-LRB-_-LRB-
RXR_NN
alpha_NN
,_,
beta_NN
,_,
gamma_NN
-RRB-_-RRB-
._.

That_IN
RA_NN
promotes_VBZ
both_CC
neutrophil_NN
and_CC
monocyte_NN
differentiation_NN
has_VBZ
implications_NNS
for_IN
the_DT
use_NN
of_IN
RA_NN
and_CC
D3_NN
in_IN
treatment_NN
of_IN
leukemias_NNS
and_CC
provides_VBZ
insight_NN
into_IN
mechanisms_NNS
whereby_WRB
RAR_NN
,_,
VDR_NN
and_CC
RXR_NN
facilitate_VBP
monocyte_NN
differentiation_NN
._.

